Pfizer Inc TRML Holdings History

Number of Shares
1.27 Mil
Current Holdings Value*
$19.35 Mil
% of Portfolio
3.86%
Total Estimate Gain
$-8.42 Mil
% of Total Estimate Gain
-26.31%

Pfizer Inc's Tourmaline Bio Inc Holding Summary

As of 2025-03-31, Pfizer Inc held 1.27 Mil shares of Tourmaline Bio Inc(TRML), totaling $19.35 Mil. This investment constitutes 3.86% of their stock portfolio, and Pfizer Inc now holds 4.95% of the outstanding Tourmaline Bio Inc(TRML) stock.

The initial trade took place in 2024Q4. Based on historical transaction data and TRML's current price of $18.54, Pfizer Inc's estimated gain on his TRML holdings is $-8.42 Mil, reflecting a -26.31% gain to date.

Pfizer Inc TRML ($18.54) Holding Chart

Pfizer Inc TRML ($18.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1